Shilpa Medicare tumbles on receiving import alert

18 Feb 2021 Evaluate

Shilpa Medicare is currently trading at Rs. 385.85, down by 40.25 points or 9.45% from its previous closing of Rs. 426.10 on the BSE.

The scrip opened at Rs. 425.00 and has touched a high and low of Rs. 425.60 and Rs. 378.25 respectively. So far 117071 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 692.45 on 11-Aug-2020 and a 52 week low of Rs. 240.30 on 31-Mar-2020.

Last one week high and low of the scrip stood at Rs. 433.00 and Rs. 410.00 respectively. The current market cap of the company is Rs. 3208.49 crore.

The promoters holding in the company stood at 53.25%, while Institutions and Non-Institutions held 19.45% and 27.30% respectively.

Shilpa Medicare has received an Import Alert 66-40 on February 17, 2021, pursuant to the USFDA inspection of the Unit 4, Jadcherla, Telangana facility from February 13 - 20 and February 24-25, 2020.

Three products have been exempted from the Import Alert - Azacitidine for Injection, Cyclophosphamide Capsules and Erlotinib Tablets.

The company is committed to address the concerns raised by the USFDA and will work with the US FDA to resolve these issues at the earliest.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

534.25 8.25 (1.57%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.